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In the last decade, the development and use of new methods in combinatorial chemistry and high-throughput screening has dramatically 
increased the number of known biologically active compounds. Paradoxically, the number of drugs reaching the market has not followed the 
same trend, often because many of the candidate drugs present poor qualities in absorption, distribution, metabolism, excretion, and 
toxicological properties (ADME-Tox). The ability to recognize and discard bad candidates early in the drug discovery steps would save lost 
investments in time and money. Machine learning techniques could provide solutions to this problem.
The goal of my research is to develop classifiers that accurately discriminate between active and inactive molecules for a specific target. To this 
end, I am comparing the effectiveness of the application of different machine learning techniques to this problem.    As a source of data we have 
selected a set of PubChem's public BioAssays¹. In addition, with the objective of realizing a real-time query service with our predictors, we aim 
to keep the features describing the chemical compounds relatively simple. 
At the end of this process, we should better understand how to build statistical models that are able to recognize molecules active in a specific 
bioassay, including how to select the most appropriate classification technique, and how to describe compounds in such a way that is not 
excessively resource-consuming to generate, yet contains sufficient information for the classification. We see immediate applications of such 
technology to recognize compounds with high-risk of toxicity, and also to suggest likely metabolic pathways that would process it.
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Approach that we have used to develop the software
 
This software must be able to predict biological or toxicological activity 
of molecules for any kind of BioAssay. In order to respect this concept, 
we have developed a tool which use structural keys to do prediction and 
not molecular descriptors which depend more on the BioAssay.
Results
For confidentiality reasons, the poster displays only the results fort just one 
PubChem BioAssay, the AID:852 or factor XIIa 1536 HTS Dose Response 
Confirmation.
Accuracy Precision Recall
SVM 92,4 % 0.92 0,81
Neural 
Networks 92,2 % 0.92 0,78
Random 
Forest 92,2 % 0.91 0,74
Naive Bayes 84 % 0,65 0,75
Software Improvements
In order to have an approach more efficient in term of classification, our 
software should be able to identify specific patterns responsible 
for the activity. 
We have developed a tool² that crop the compound into fragments which 
consist in single rings, Murko fragments, conjugated structures and 
linkers.
This approach will be used for features selection and to determine if the 
presence of specific patterns or combination of them can modify the 
activity of the compound since each fragment is related to the activity 
score of the compound. This second concept is similar to the structure-
activity relationship process (SAR).
Fragmentation of all compounds of PubChem BioAssay 852 
We get 5315 unique fragments on which we apply a filter, We removed all 
the fragments which are present in:
1 active and 0 inactive
0 active and 1 inactive
x active and  x inactive (where x is any number)
Finally we retrieve 694 fragments:
397 fragments present only in inactive molecules
173 fragment present only in active molecules
for example the compound with the accession number CID:2317506 who 
has a high activity score for this BioAssay will be cropped like this.
The fragmentation tool can also crop the compound in single rings and 
linkers but there are not present in the example above.
All the fragment are then used to generate a network in order to display if 
the combination of them have an impact on biological activity.
Future
Test the software with experimental data synthesized by the CNR 
laboratory.
Try to improve the prediction on BioAssays which present an unbalanced 
data distribution.
Add a function of the fragmentation tool to keep the side chain of the 
compound which contains specific atoms like halogens or sulfur in order 
to generate a better compound network
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